Peptides vs SARMs: Two Different Research-Chemical Categories
Growth-hormone peptides and SARMs are both sold as research chemicals for muscle. Different molecules, different regulatory and WADA histories, side by side.
The short version
Peptides such as ipamorelin and CJC-1295, and SARMs, are often shopped for the same reason: muscle and body composition. They are chemically unrelated. A peptide is a short amino-acid chain; a SARM is a synthetic small molecule. Neither category has an FDA-approved product sold for that use. Both sit in the same unregulated research-chemical market, and both are banned in sport at all times.
- Peptides and SARMs are different classes of molecule, not two versions of the same thing.
- Neither category has an FDA-approved product marketed for muscle or performance.
- FDA has published a specific consumer warning naming SARMs and their reported harms.
- Both categories are prohibited in sport at all times, under different WADA sections.
Peptide vendors and SARM vendors sell into the same market: people looking to add muscle or change body composition outside a prescription. The molecules are unrelated, and neither category has an approved product for that use.
This page compares what they are, not which one “works better”. This site does not rank unapproved research chemicals.
What they are
| Peptides (e.g. ipamorelin, CJC-1295) | SARMs | |
|---|---|---|
| Molecule type | Chains of amino acids - short protein fragments | Synthetic small-molecule chemicals, structurally unrelated to steroids or amino-acid chains |
| How they’re described here | Growth hormone secretagogue / GHRH analogue peptides, sold to raise growth hormone and IGF-1 | Chemicals that bind the androgen receptor, marketed to mimic effects associated with testosterone and anabolic steroids |
| Typical delivery | Injected (subcutaneous) | Usually oral (tablet or liquid) |
| Marketed for | Muscle, recovery, body composition, energy | Muscle, strength, body composition |
| FDA-approved for this use | No | No |
Full pages: Ipamorelin · CJC-1295 · Compounds index
FDA’s position on SARMs
FDA has published a consumer warning that “SARMs cannot be legally marketed in the U.S. as a dietary supplement or drug at this time”. The warning describes SARMs as chemical substances that mimic the effects of testosterone and anabolic steroids. It is aimed at teenagers and young adults who encounter them through social media marketing.
FDA lists these reported health problems associated with SARMs:
- increased risk of heart attack and stroke
- psychosis and hallucinations
- sleep disturbance
- sexual dysfunction
- liver injury, up to acute liver failure
- infertility
- pregnancy miscarriage
- testicular shrinkage
A separate FDA page on bodybuilding products says the agency has issued warning letters to companies selling unapproved products marketed as SARMs, and has pursued criminal actions against distributors. It also reports lab-testing one such product, sold as containing the SARM YK-11, after a consumer adverse event report. The labelled SARM was present, alongside an undeclared anabolic steroid.
FDA has not published an equivalent named consumer update for growth-hormone-secretagogue peptides. That does not mean less scrutiny. Ipamorelin acetate appears in FDA’s own category-2 table of nominated bulk substances with identified potential significant safety risks, described on its own page. The two categories have been flagged through different FDA processes, and neither has been cleared.
WADA status
Both categories are prohibited in sport at all times, under different sections of the WADA Prohibited List:
| Peptides (ipamorelin, CJC-1295) | SARMs | |
|---|---|---|
| WADA section | S2 - Peptide Hormones, Growth Factors, Related Substances and Mimetics (S2.2.4, growth hormone secretagogues/releasing factors) | S1 - Anabolic Agents (S1.2, Other Anabolic Agents) |
| When prohibited | All times (in and out of competition) | All times (in and out of competition) |
| Therapeutic use exemption | Not established for these unapproved uses | Not established |
Read directly on wada-ama.org, the WADA Prohibited List confirms that both S1 (Anabolic Agents) and S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics) are “all times” categories.
Its S1.2 entry, “Other Anabolic Agents,” names selective androgen receptor modulators explicitly, with the examples andarine, enobosarm (ostarine), ligandrol (LGD-4033), RAD140, S-23 and YK-11. The list is non-exhaustive, so a SARM not named there is not automatically permitted.
Ipamorelin and CJC-1295 are each named explicitly under S2.2.4. Their own pages cite this to a national anti-doping agency mirror of the list.
Evidence
Neither category has a finished human efficacy programme for muscle or body composition in healthy adults.
- Ipamorelin: its own page rates the evidence limited. The selectivity finding it is known for is animal and in vitro data. Human evidence is a single Phase 1 pharmacokinetic study that could not be retrieved, plus a Phase 2 programme in postoperative ileus that was discontinued for insufficient efficacy.
- CJC-1295: its own page also rates the evidence limited. Human pharmacokinetic data exists only for the with-DAC form, and it is surrogate hormone measures rather than clinical outcomes. Development was likewise discontinued at Phase 2.
For SARMs, FDA’s language is an enforcement and safety warning, not a study-design rating. It describes them as unapproved drugs FDA has not reviewed for safety or effectiveness, marketed as supplements when they are not supplements. It also cites adverse event reports FDA has received directly. That is a different kind of statement from an evidence-level rating, but it points the same way: no regulator-reviewed human efficacy package exists for consumer use of either category.
Risks, side by side
| Peptides (ipamorelin, CJC-1295) | SARMs | |
|---|---|---|
| Reported harms | No long-term human safety data; development for both was halted at Phase 2, not because safety was established | FDA lists heart attack, stroke, psychosis, hallucinations, sleep disturbance, sexual dysfunction, liver injury and acute liver failure, infertility, miscarriage, testicular shrinkage |
| Supply chain | Sold as research chemicals, not legally marketed for human use; identity, purity and dose unverified | FDA reports lab-testing one product labelled to contain a SARM and finding an undeclared anabolic steroid present alongside it |
| Regulatory action | Ipamorelin acetate in FDA’s category-2 nominated-substance table | FDA warning letters and criminal actions against sellers |
| Sport status | Prohibited at all times (WADA S2.2.4) | Prohibited at all times (WADA S1.2) |
Related
- Ipamorelin · CJC-1295
- BPC-157 vs TB-500
- Peptide side effects
- Research peptides and the law
- Compounds index
Common questions
Are SARMs peptides?
No. SARMs (selective androgen receptor modulators) are synthetic small-molecule chemicals. A peptide is a chain of amino acids; a SARM is not.
Is either category FDA-approved for muscle or performance?
No. FDA has not approved any SARM for any use, and none of the growth-hormone peptides compared on this page are FDA-approved for muscle, body composition or performance in healthy adults.
Are SARMs and these peptides legal to buy?
Both are sold through research-chemical and grey-market channels in the US without FDA approval for human use. FDA has published a consumer warning stating SARMs cannot legally be marketed as a dietary supplement or drug. The peptides compared here carry the same research-only status on their own pages.
Which is safer, peptides or SARMs?
This page does not rank them. Their risks differ and are largely unstudied in humans, and neither has the safety record of an approved medicine. See the risks section on each compound's own page.
Do peptides really build muscle?
No completed human trial has shown ipamorelin or CJC-1295 building muscle in healthy adults. Both raise growth hormone and IGF-1, which is a hormone measurement, not a measured change in muscle mass or strength. Development of both stopped at Phase 2, before either reached a finished efficacy trial for muscle or body composition.
What is the downside of taking peptides?
The peptides compared here have no long-term human safety data, an unregulated supply chain, and an all-times ban in sport. Ipamorelin and CJC-1295 development stopped at Phase 2, not because safety was established. They are sold as research chemicals, so no regulator verifies identity, purity or dose before sale. Ipamorelin acetate sits in FDA's category-2 table of nominated bulk substances with identified potential significant safety risks.
What is the most risky peptide?
This page does not rank individual peptides by risk. Risk depends on the compound: how much human data exists, whether FDA has flagged it in its own review process, and how anti-doping rules treat it. Check each peptide's own page on this site for its evidence rating and listed risks before assuming one is safer than another.
What peptides does Joe Rogan take?
The one peptide Joe Rogan has named in a statement confirmed by two sources is BPC-157. In July 2021 he said on his podcast that it cleared elbow tendonitis within two weeks. He also said he had an NAD drip, which is not a peptide, while ill with COVID-19. Neither statement says what he takes now; see /joe-rogan-peptides/. When peptides come up alongside SARMs in that kind of discussion, they usually mean growth-hormone secretagogues such as ipamorelin and CJC-1295, the pair compared on this page. Neither is FDA-approved for muscle, body composition or performance. Both stopped in Phase 2 development, and both are sold as research chemicals. Their own pages give the evidence and legal status in full.
Are peptides steroids?
No. A peptide is a short chain of amino acids; anabolic steroids are synthetic relatives of testosterone, a different kind of molecule altogether. The WADA Prohibited List also keeps them apart. Anabolic agents sit under section S1, and growth-hormone peptides such as ipamorelin and CJC-1295 sit under S2. Both sections are banned at all times.
Do peptides work better than steroids?
There is no evidence to say so. I found no trial comparing them, and this site does not rank unapproved compounds. The growth-hormone peptides compared here raise growth hormone and IGF-1, but no finished human trial has shown them building muscle in healthy adults, and their development stopped at Phase 2. The evidence section above sets out what does exist.
References (4 sources)
Bibliographic detail is fetched from PubMed, not written by me - so a citation here cannot drift from the paper it names. Study design comes from PubMed's own tags rather than my judgement.
- 1.The Joe Rogan Experience #1683 (with Andrew Huberman), 14 July 2021, episode transcript: Rogan describes elbow tendonitis cleared after starting BPC-157.- Podscripts (episode transcript)other
- 2.FDA warns against use of selective androgen receptor modulators (SARMs), stating they cannot legally be marketed as a dietary supplement or drug, and listing reported harms including heart attack, stroke, psychosis, liver injury and infertility.- US Food and Drug Administrationregulatory
- 3.FDA - Certain bodybuilding products, including those containing SARMs, put consumers at risk of heart attack, stroke and serious liver damage; page also describes warning letters and criminal actions against sellers.- US Food and Drug Administrationregulatory
- 4.WADA 2026 Prohibited List - S1 Anabolic Agents (covering SARMs, all times) and S2 Peptide Hormones, Growth Factors, Related Substances and Mimetics (covering GH-secretagogue peptides, all times).- World Anti-Doping Agencyregulatory